As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these Tax transparency and international co-operation Enhanced ...

Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining ...

Image: Sanjay Rawat India’s pharmaceutical sector is at a tipping point and over the next decade it could redefine operational strategies to tap the potential opportunities unlocking the next level of ...

For years, Jeff Simmons — the president and CEO of the large US pharmaceutical company Elanco — ridiculed a seemingly unlikely target on social media: the plant-based meat industry.

BERKELEY HEIGHTS, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

TABUK CITY, Kalinga — Two students are in critical condition after they were shot by unidentified assailants in Bulanao in this city on early Wednesday morning. The victims, identified as Keith ...

Feb 27 (Reuters) - Sycamore Partners is planning a three-way split of Walgreens Boots Alliance (WBA.O), opens new tab if a deal to take the struggling pharmacy chain private is reached, the ...

including pharmaceutical materials, from waste. This breakthrough marks a major step toward more sustainable energy and chemical production. Their findings were published today (February 27) in Nature ...

Credit: JHVEPhoto/Shutterstock. Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical manufacturing sites. The move increases the ...

Saudi Arabia Pharmaceutical Drugs Market Trend and Size Saudi Arabia pharmaceutical drugs market is estimated to be valued at US$ 12.60 billion in 2023 and is expected to exhibit a CAGR of 7.6% by 202 ...